Can a newer treatment help #lymphoma patients considered “low-risk”? A real-world study across 17 hospitals in China found that 92.6% of evaluable patients with diffuse large B-cell lymphoma achieved complete remission after Pola-R-CHP treatment. Promising results!👇
link.springer.com/article/10.1...
